Rwq Financial Management Services, Inc. Abb Vie Inc. Transaction History

Rwq Financial Management Services, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $274,276 - $348,695	-1,993 Closed	0 $0
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $6,598 - $8,187	-50 Reduced 2.45%	1,993 $323,000
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $41,145 - $52,061	-383 Reduced 15.79%	2,043 $277,000
Q3 2021 Nov 03, 2021	SELL	$106.4 - $120.78 $4.88 Million - $5.55 Million	-45,910 Reduced 94.98%	2,426 $262,000
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $762,351 - $849,303	-7,246 Reduced 13.04%	48,336 $5.45 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $363,062 - $399,688	3,549 Added 6.82%	55,582 $6.02 Million
Q4 2020 Mar 08, 2021	BUY	$80.49 - $108.67 $4.19 Million - $5.65 Million	52,033 New	52,033 $5.58 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Rwq Financial Management Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Rwq Financial Management Services, Inc. with notifications on news.